SIR-It has been recently reported that the 5
0 end of Neuregulin 1 gene (NRG1) is associated with schizophrenia in Icelandic and Scottish populations.
1,2 We confirmed this finding in the present case-control study in a Chinese sample, which analyzed 13 microsatellites extending about 360 kb from upstream of NRG1 to the first intron.
The subjects consisted of 540 unrelated schizophrenic in-patients and 279 controls. All case samples were collected from the Shanghai Mental Health Center. Clinical diagnosis was made according to DSM-IIIR criteria by two independent clinicians. A standard informed consent, which was reviewed and approved by the Shanghai Ethical Committee of Human Genetic Resources, was granted by all the participants. Control individuals were from attendees at hematology clinics in Shanghai. From the polymorphisms used by Stefansson et al 1 for genotyping, we chose 13 microsatellite markers, which span around an 800 kb region of chromosome 8pter. The genotyping assay was performed on MegaBACE 1000 instruments (Amersham Biosciences).
Genotype distributions were within Hardy-Weinberg equilibrium in both patients and controls for all the markers except D8S1769, which was then excluded in the later association analysis. Differences in allelic and haplotypic distributions were estimated using the program CLUMP 1.6, 3 with more than 10 000 simulations. Statistically significant differences in allele distributions were observed between schizophrenics and controls on four microsatellite markers (Table 1 ). According to the standardized pairwise disequilibrium D 04 values, the 13 markers can be divided into four regions: the first two markers (D8S1770 and D8S1769); the four markers upstream of NRG1 gene (29H12-7320 through 478B14-642); the five markers in the first intron (487-2 through 420M9-3663); and the last two markers (473C15-439 and 72H22-1) ( Table 1 ). In general, the D 0 values greater than 0.3 were observed between the markers within the same regions, while hardly between site pairs from different regions. Calculations of the significance of LD revealed a similar pattern. As a result of this LD pattern, haplotype analysis was performed in each region separately. PHASE 5 software was applied to estimate the multiple marker haplotype frequencies, then haplotypes with an estimated frequency greater than 1% were included for the w 2 test using CLUMP.
3 For regions 2 and 3, haplotypes with probabilities greater than 1% accounted for the vast majority of the haplotype diversity (82 and 80%, respectively), and overall frequency comparisons showed significant differences between cases and controls (T2, X 2 ¼57.80, 19 df, P¼0.00003; T2, X 2 ¼49.23, 19 df, P¼0.000267, respectively). The statistic T3 produced by CLUMP for region 2 revealed that the difference reflected mainly different distributions of haplotype '0/2/0/2' (frequency¼1.45 and 4.4%, for case and control group, separately; T3, X 2 ¼13.80, 1 df, P¼0.0036; OR¼0.31, 95% CI: 0.16-0.59). For region 3, the greatest contribution to the w 2 total came from the haplotype '20/4/-2/18/0' (frequency¼35.8 and 27.2%, for case and control group, separately; T3, X 2 ¼11.80, 1 df, P¼0.014; OR¼1.49, 95% CI: 1.19-1.87). For region 4, the two-marker haplotype of 473C15-439 and 72H22-1 yielded no significant P-values (Table 1) . Since the microsatellite markers 478B14-642, 487-2, 478B14-848, and 420M9-1395 overlapped the region of the core at-risk haplotype identified in the Icelandic and Scottish samples, we also analyzed the haplotypes of these four markers, finding the P-values were above the significant level (T2, X 2 ¼15.91, 19 df, P¼0.6632).
Stefansson et al
1 recently identified NRG1 gene as a susceptibility gene of schizophrenia and they narrowed the region of interest to the 5 0 end of the NRG1 gene, which was well confirmed by our present study with different ethnic population from southern China. However, the markers constituting the at-risk haplotypes were not exactly same in the two studies, and the odds ratios estimated in this study were lower than those in Stefansson's work. One possible explanation for the inconsistency is that somewhat different disequilibrium patterns exist between the two populations. In Stefansson's study, they showed that the region of the core at-risk haplotype overlapped the microsatellites 478B14-642, 487-2, 478B14-848, and 420M9-1395, exhibiting extensive linkage disequilibrium, whereas in our study only the last three markers revealed a tight LD with each other. Such variation in LD relationships found in different populations may lead to discrepant findings confounding association results with the different risk haplotypes.
Although our statistical results indicate the 5 0 end of NRG1 associated with schizophrenia in our sample, confirmed by either single marker analysis or haplotype analysis, there are still several problems. First, since both of the adjoining regions in the NRG1 gene indicated association with schizophrenia, a stratified analysis should be performed to evaluate the independent effect of regions 2 and 3. However, it is difficult for the software PHASE to construct the haplotypes across the two loosely linked regions in unrelated individuals due to the huge uncertainty associated with each phase call. Furthermore, for these two regions, no individual haplotype capture the same degree of association as the overall haplotypes in the global test. To clarify these issues, it will be helpful to conduct family-based association studies in independent samples for the identification of ancestral at-risk haplotypes with combined microsatellites and SNPs. 1 The majority (7/10) of these patients harbored sequences related to the HERV-W family of human endogenous retroviruses. In the present study, we tested plasma from first hospitalized patients with DSM IV schizophrenia, schizoaffective psychosis, or schizophreniform disor- 
